158 related articles for article (PubMed ID: 3489966)
1. Specific binding of human pancreatic secretory trypsin inhibitor to various cultured cells.
Niinobu T; Ogawa M; Shibata T; Murata A; Nishibe S; Mori T; Ogata N
Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):245-8. PubMed ID: 3489966
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical distribution of trypsinogen and pancreatic secretory trypsin inhibitor in normal and neoplastic tissues in man.
Marks WH; Ohlsson K; Polling A
Scand J Gastroenterol; 1984 Jul; 19(5):673-6. PubMed ID: 6382569
[TBL] [Abstract][Full Text] [Related]
3. Secretion of pancreatic secretory trypsin inhibitor by cultured human carcinoma cells.
Ogawa M; Yamaguchi N; Chung SM; Shiroeda O; Shibata T; Mori T
J Med; 1988; 19(1):13-9. PubMed ID: 3221140
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic secretory trypsin inhibitor, cathodal trypsin, and pancreatic elastase in pancreatic juice collected at endoscopic retrograde cholangiopancreatography.
Marks WH; Ohlsson K; Wehlin L; Russick C
Curr Surg; 1985; 42(1):26-8. PubMed ID: 3844336
[No Abstract] [Full Text] [Related]
5. Zymogen activation: effect of peptides sequentially related to the bovine beta-trypsin N-terminus on Kazal inhibitor and benzamidine binding to bovine trypsinogen.
Ascenzi P; Coletta M; Amiconi G; Bolognesi M; Guarneri M; Menegatti E
J Mol Recognit; 1988 Jun; 1(3):130-7. PubMed ID: 3273224
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic secretory trypsin inhibitor immunoreactivity detected in serum-free culture medium of human pancreatic carcinoma cell line, CAPAN-1.
Ogata N; Murata A
Res Commun Chem Pathol Pharmacol; 1988 Feb; 59(2):233-44. PubMed ID: 3358013
[TBL] [Abstract][Full Text] [Related]
7. [Conformational aspects of beta-trypsin interaction with substrates and pancreatic trypsin inhibitor. III. Catalytic act of trypsin and its inhibition].
Popov EM; Godzhaev NM; Aliev RE
Mol Biol (Mosk); 1986; 20(2):357-68. PubMed ID: 3702867
[TBL] [Abstract][Full Text] [Related]
8. Trypsin inhibitors in bovine lung and pancreas during development.
Wilusz T; Wilimowska-Pelc A; Mejbaum-Katzenellenbogen W
Acta Biochim Pol; 1976; 23(2-3):269-75. PubMed ID: 9760
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of DNA synthesis in human fibroblasts by human pancreatic secretory trypsin inhibitor.
Ogawa M; Tsushima T; Ohba Y; Ogawa N; Tanaka S; Ishida M; Mori T
Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):155-8. PubMed ID: 3909270
[TBL] [Abstract][Full Text] [Related]
10. Autophagic cell death of pancreatic acinar cells in serine protease inhibitor Kazal type 3-deficient mice.
Ohmuraya M; Hirota M; Araki M; Mizushima N; Matsui M; Mizumoto T; Haruna K; Kume S; Takeya M; Ogawa M; Araki K; Yamamura K
Gastroenterology; 2005 Aug; 129(2):696-705. PubMed ID: 16083722
[TBL] [Abstract][Full Text] [Related]
11. Purification and identification of a binding protein for pancreatic secretory trypsin inhibitor: a novel role of the inhibitor as an anti-granzyme A.
Tsuzuki S; Kokado Y; Satomi S; Yamasaki Y; Hirayasu H; Iwanaga T; Fushiki T
Biochem J; 2003 May; 372(Pt 1):227-33. PubMed ID: 12590650
[TBL] [Abstract][Full Text] [Related]
12. [Value of pancreatic secretory trypsin inhibitor by radioimmunoassay in diagnosis of pancreatic diseases].
Chen BG
Zhonghua Wai Ke Za Zhi; 1988 Dec; 26(12):714-6, 780. PubMed ID: 3248462
[No Abstract] [Full Text] [Related]
13. Binding of the bovine pancreatic secretory trypsin inhibitor (Kazal) to bovine serine (pro)enzymes.
Menegatti E; Guarneri M; Bolognesi M; Ascenzi P; Amiconi G
J Mol Biol; 1987 Nov; 198(1):129-32. PubMed ID: 3430603
[TBL] [Abstract][Full Text] [Related]
14. Elevation of serum immunoreactive pancreatic secretory trypsin inhibitor contents in various malignant diseases.
Matsuda K; Ogawa M; Murata A; Kitahara T; Kosaki G
Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):301-5. PubMed ID: 6878869
[TBL] [Abstract][Full Text] [Related]
15. Competition of a growth stimulating-/cholecystokinin (CCK) releasing-peptide (monitor peptide) with epidermal growth factor for binding to 3T3 fibroblasts.
Fukuoka S; Fushiki T; Kitagawa Y; Sugimoto E; Iwai K
Biochem Biophys Res Commun; 1987 Jun; 145(2):646-50. PubMed ID: 3496093
[TBL] [Abstract][Full Text] [Related]
16. Primary amino acid sequence similarity between human epidermal growth factor-urogastrone, human pancreatic secretory trypsin inhibitor, and members of porcine secretin family.
Scheving LA
Arch Biochem Biophys; 1983 Oct; 226(2):411-3. PubMed ID: 6605724
[TBL] [Abstract][Full Text] [Related]
17. Postoperative elevation of serum pancreatic secretory trypsin inhibitor.
Matsuda K; Ogawa M; Shibata T; Nishibe S; Miyauchi K; Matsuda Y; Mori T
Am J Gastroenterol; 1985 Sep; 80(9):694-8. PubMed ID: 2412437
[TBL] [Abstract][Full Text] [Related]
18. [Soluble high molecular weight derivatives of pancreatic trypsin inhibitor. Effect of electrostatic interaction of protein with the carrier on covalent binding and some physico-chemical properties of modified preparations of pancreatic inhibitor].
Larionova NI; Kazanskaia NF; Sakharov IIu; Berezin IV
Biokhimiia; 1979 Nov; 44(11):2033-8. PubMed ID: 546446
[TBL] [Abstract][Full Text] [Related]
19. Distribution of pancreatic secretory trypsin inhibitor in various human tissues and its inactivation in the gastric mucosa.
Shibata T; Ogawa M; Takata N; Matsuda K; Niinobu T; Uda K; Wakasugi C; Mori T
Res Commun Chem Pathol Pharmacol; 1987 Feb; 55(2):243-8. PubMed ID: 3823611
[TBL] [Abstract][Full Text] [Related]
20. Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture.
Fitzpatrick SL; LaChance MP; Schultz GS
Cancer Res; 1984 Aug; 44(8):3442-7. PubMed ID: 6331647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
